Michael Robilotti
Physician Assistant · Staten Island, NYNPI 1285949859
Payments from drug & device makers
Across 114 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$355
- Tolmar, Inc.$328
- Astellas Pharma US Inc$260
- Sumitomo Pharma America, Inc.$102
- Progenics Pharmaceuticals, Inc.$93
- Amgen$91
- plus $687 from 20 others
What the payments were for
- Food & beverage$1,916100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 23 | $355 |
| Tolmar, Inc. | 17 | $328 |
| Astellas Pharma US Inc | 19 | $260 |
| Sumitomo Pharma America, Inc. | 5 | $102 |
| Progenics Pharmaceuticals, Inc. | 4 | $93 |
| Amgen | 5 | $91 |
| Urovant Sciences Inc | 4 | $83 |
| Bayer | 5 | $74 |
| AbbVie | 4 | $73 |
| Myovant Sciences Inc. | 3 | $47 |
| Immunitybio, Inc. | 3 | $45 |
| Civco Medical Instruments | 2 | $42 |
| Merck | 2 | $38 |
| Teleflex LLC | 2 | $35 |
| Tolmar Pharmaceuticals, Inc. | 2 | $30 |
| Verity Pharmaceuticals Inc. | 2 | $30 |
| Boston Scientific | 2 | $30 |
| Dendreon Pharmaceuticals LLC | 2 | $27 |
| Palette Life Sciences, Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Endo USA, Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $18 |
| Procept Biorobotics Corporation | 1 | $16 |
| Bioprotect Medical, Inc. | 1 | $14 |
| ABC Home Medical Supply, Inc. | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
How this compares
$1,916 in reported general payments places this provider in the 85th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 130 | $107,877 |
| GemtesaVibegron | 29 | $32,978 |
| Mirabegron ErMirabegron | 33 | $18,001 |
| Tamsulosin Hcl | 605 | $10,056 |
| Trospium Chloride ErTrospium Chloride | 51 | $9,774 |
| Silodosin | 44 | $5,211 |
| Dutasteride | 136 | $4,379 |
| Estradiol | 20 | $3,371 |
| Potassium Citrate ErPotassium Citrate | 40 | $2,852 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 100 | $2,651 |
| Dutasteride-TamsulosinDutasteride/Tamsulosin Hcl | 12 | $2,231 |
| YuvafemEstradiol | 20 | $2,154 |
| Finasteride | 146 | $2,011 |
| Solifenacin Succinate | 25 | $1,971 |
| Oxybutynin Chloride ErOxybutynin Chloride | 81 | $1,646 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $260 | $107,877130 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $102 | $32,97829 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Staten Island
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
- Cameron KiserNew York$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.